YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Tofacitnib for the Treatment of Alopecia Areata and Variants

Phase 2

Completed

Conditions: Alopecia Universalis (AU)
Alopecia Areata (AA)
Alopecia Totalis (AT)

Interventions: Drug: Tofacitinib Administration

First Posted Date: 2014-07-22

Last Posted Date: 2017-04-04

Lead Sponsor: Yale University

Target Recruit Count: 30

Registration Number: NCT02197455

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver.

Not Applicable

Completed

Conditions: Insulin Resistance

Interventions: Other: one bout of 45 minutes exercise

First Posted Date: 2014-07-21

Last Posted Date: 2024-08-15

Lead Sponsor: Yale University

Target Recruit Count: 41

Registration Number: NCT02196051

Locations: 🇺🇸
YCCI/YNNH Hospital Research Unit, New Haven, Connecticut, United States

Comparison of Nasal Steroids After FESS in CRSwNP

Not Applicable

Completed

Conditions: Sinusitis
Nasal Polyps

Interventions: Drug: fluticasone nasal spray
Drug: Budesonide head upright
Drug: Budesonide head forward

First Posted Date: 2014-07-18

Last Posted Date: 2018-02-08

Lead Sponsor: Yale University

Target Recruit Count: 32

Registration Number: NCT02194062

Locations: 🇺🇸
Yale Physicians Bldg, New Haven, Connecticut, United States
🇺🇸
Yale ENT Stratford, Stratford, Connecticut, United States

The Effects of Minocycline in Humans

Phase 1

Completed

Conditions: Memory Impairment

Interventions: Drug: Sugar pill
Drug: Minocycline

First Posted Date: 2014-07-17

Last Posted Date: 2019-09-19

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT02193269

Locations: 🇺🇸
Veteran Affairs Hospital, West Haven, Connecticut, United States

Reversal of Lipid-Induced Insulin Resistance

Not Applicable

Recruiting

Conditions: Insulin Resistance
NAFLD

Interventions: Behavioral: Caloric Restriction

First Posted Date: 2014-07-17

Last Posted Date: 2025-05-16

Lead Sponsor: Yale University

Target Recruit Count: 250

Registration Number: NCT02193295

Locations: 🇺🇸
Yale Center for Clinical Investigation HRU, New Haven, Connecticut, United States
🇺🇸
Magnetic Resonance Research Center (MRRC), New Haven, Connecticut, United States

Chronic Alcohol, Stress Inflammatory Response and Relapse Risk

Not Applicable

Completed

Conditions: Alcohol Dependence
Depressive Symptomatology

Interventions: Behavioral: Personal Stress Imagery
Behavioral: Neutral Imagery

First Posted Date: 2014-07-17

Last Posted Date: 2020-03-06

Lead Sponsor: Yale University

Target Recruit Count: 116

Registration Number: NCT02193204

Locations: 🇺🇸
CT Mental Health Center, New Haven, Connecticut, United States

Varenicline + Prazosin for Heavy Drinking Smokers

Early Phase 1

Completed

Conditions: Alcohol Use Disorders
Cigarette Smoking

Interventions: Drug: Varenicline
Drug: Placebo
Drug: Prazosin

First Posted Date: 2014-07-17

Last Posted Date: 2020-03-12

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT02193256

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Text Messaging for Smoking Cessation in College Health Clinics

Not Applicable

Completed

Conditions: Cigarette Smoking

Interventions: Behavioral: Smoking counseling
Behavioral: Text messaging
Drug: Nicotine patch

First Posted Date: 2014-07-15

Last Posted Date: 2020-04-01

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT02191033

Locations: 🇺🇸
Southern Connecticut State University, New Haven, Connecticut, United States

Mindfulness Interventions and Chronic Widespread Pain in Adolescents

Not Applicable

Completed

Conditions: Chronic Widespread Pain
Fibromyalgia

Interventions: Behavioral: Mindfulness Group

First Posted Date: 2014-07-15

Last Posted Date: 2017-03-03

Lead Sponsor: Yale University

Target Recruit Count: 29

Registration Number: NCT02190474

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Minocycline's Effects on Alcohol Responses in Humans

Phase 1

Completed

Conditions: Alcohol Dependence

Interventions: Drug: Placebo (for Minocycline)
Drug: Minocycline

First Posted Date: 2014-07-10

Last Posted Date: 2020-03-09

Lead Sponsor: Yale University

Target Recruit Count: 54

Registration Number: NCT02187211

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy